] NEW YORK (Reuters) - Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International VRX.TO, will receive a $9 million severance payment and agreed to a consulting agreement worth hundreds of thousands of dollars, according to a document filed with regulators...